![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
ProMIS Neurosciences secures $20M+ PIPE; Beam Therapeutics reveals data ahead of IND
ProMIS Neurosciences, a biotech focused on developing treatments for neurodegenerative diseases, closed a private investment in public equity, or PIPE, that brought in $20.4 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.